Detalhe da pesquisa
1.
In vivo reprogramming of wound-resident cells generates skin epithelial tissue.
Nature
; 561(7722): 243-247, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185909
2.
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Cancer Sci
; 111(10): 3902-3911, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748499
3.
Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation.
FASEB J
; 33(4): 5300-5311, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681884
4.
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974.
Methods
; 154: 10-20, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326272
5.
LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation.
Nucleic Acids Res
; 46(11): 5441-5454, 2018 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618057
6.
Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.
Exp Dermatol
; 27(1): 14-21, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714851
7.
Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.
Int J Cancer
; 138(2): 428-39, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26240060
8.
Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A.
Blood
; 124(20): 3165-71, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274508
9.
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer.
Cancer Immunol Res
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558120
10.
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.
Cancer Immunol Res
; : OF1-OF12, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563577
11.
LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα.
Blood Adv
; 5(9): 2305-2318, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929501
12.
A Novel Total Drug Assay for Quantification of Anti-C5 Therapeutic Monoclonal Antibody in the Presence of Abundant Target.
AAPS J
; 23(1): 21, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415498
13.
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation.
Cancer Discov
; 11(1): 158-175, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847940
14.
Design and synthesis of peptidomimetic factor VIIa inhibitors.
Chem Pharm Bull (Tokyo)
; 58(1): 38-44, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20045964
15.
Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2.
Cell Rep
; 29(1): 89-103.e7, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577958
16.
Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
Bioorg Med Chem Lett
; 18(16): 4533-7, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18674905
17.
[Three cases demonstrating the characteristic neuroimaging of reversible posterior leukoencephalopathy syndrome].
No Shinkei Geka
; 36(5): 423-8, 2008 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-18516860
18.
The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
Cell Rep
; 18(9): 2148-2161, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249161
19.
Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.
Sci Rep
; 7(1): 1080, 2017 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439081
20.
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors.
Sci Transl Med
; 9(410)2017 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978751